Paper37499080
Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): Development, insights, and impact.
Scott AB and 2 others. Medicine (Baltimore), 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): Development, insights, and impact. Papers, record 37499080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37499080
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): Development, insights, and impact.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Botulinum Toxins, Type A | Major topic |
| Blepharospasm | Major topic |
| Strabismus | Major topic |
| Humans | |
| Activities of Daily Living | |
| Quality of Life |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07180394 | Botulinum Toxin for Strabismus Treatment | Background |
Source ClinicalTrials.gov
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22234840 | History of the 'geste antagoniste' sign in cervical dystonia. | J Neurol | 2012 | https://conductscience.org/library/papers/22234840 | PubMed |
| 2 | 24786379 | Sustained improvement of reading symptoms following botulinum toxin A injection for convergence insufficiency. | Strabismus | 2014 | https://conductscience.org/library/papers/24786379 | PubMed |
| 3 | 17212988 | Botulinum toxin in ophthalmology. | Surv Ophthalmol | 2007 | https://conductscience.org/library/papers/17212988 | PubMed |
| 4 | 23380701 | Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. | Toxicon | 2013 | https://conductscience.org/library/papers/23380701 | PubMed |
| 5 | 12465070 | Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. | Mov Disord | 2002 | https://conductscience.org/library/papers/12465070 | PubMed |
| 6 | 1579114 | Properties and use of botulinum toxin and other microbial neurotoxins in medicine. | Microbiol Rev | 1992 | https://conductscience.org/library/papers/1579114 | PubMed |
| 7 | 6838174 | Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. | Ann Neurol | 1983 | https://conductscience.org/library/papers/6838174 | PubMed |
| 8 | 1845036 | Clinical use of botulinum toxin. National Institutes of Health Consensus Development Conference Statement, November 12-14, 1990. | Arch Neurol | 1991 | https://conductscience.org/library/papers/1845036 | PubMed |
| 9 | 31012389 | Global and regional prevalence of strabismus: a comprehensive systematic review and meta-analysis. | Strabismus | 2019 | https://conductscience.org/library/papers/31012389 | PubMed |
| 10 | 11835433 | Epidemiology of primary blepharospasm. | Mov Disord | 2002 | https://conductscience.org/library/papers/11835433 | PubMed |
| 11 | 7243198 | Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. | Ophthalmology | 1980 | https://conductscience.org/library/papers/7243198 | PubMed |
| 12 | 18458230 | Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. | Neurology | 2008 | https://conductscience.org/library/papers/18458230 | PubMed |
| 13 | 28186662 | Blepharospasm 40 years later. | Mov Disord | 2017 | https://conductscience.org/library/papers/28186662 | PubMed |
| 14 | 27064462 | Blepharospasm: Update on Epidemiology, Clinical Aspects, and Pathophysiology. | Front Neurol | 2016 | https://conductscience.org/library/papers/27064462 | PubMed |
| 15 | 6363970 | Cranial dystonia: double-blind crossover study of anticholinergics. | Neurology | 1984 | https://conductscience.org/library/papers/6363970 | PubMed |
| 16 | 3977705 | Botulinum A toxin injection as a treatment for blepharospasm. | Arch Ophthalmol | 1985 | https://conductscience.org/library/papers/3977705 | PubMed |
| 17 | 7991136 | Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. | Neurology | 1994 | https://conductscience.org/library/papers/7991136 | PubMed |
| 18 | 31025814 | The Danish Rural Eye Study: prevalence of strabismus among 3785 Danish adults - a population-based cross-sectional study. | Acta Ophthalmol | 2019 | https://conductscience.org/library/papers/31025814 | PubMed |
| 19 | 7236103 | Blepharospasm surgery. An anatomical approach. | Arch Ophthalmol | 1981 | https://conductscience.org/library/papers/7236103 | PubMed |
| 20 | 19648904 | Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes. | Eye (Lond) | 2010 | https://conductscience.org/library/papers/19648904 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42180227 | Intervention effects of different brands of botulinum toxin type A on Meige syndrome with anxiety symptoms. | Front Neurol | 2026 | https://conductscience.org/library/papers/42180227 | PubMed |
| 41584320 | High Dose AbobotulinumtoxinA for Blepharospasm: A Case Report on the Safety and Efficacy of 500 Units of AbobotulinumtoxinA. | Tremor Other Hyperkinet Mov (N Y) | 2026 | https://conductscience.org/library/papers/41584320 | PubMed |
| 40002825 | Botulinum Neurotoxins as Two-Faced Janus Proteins. | Biomedicines | 2025 | https://conductscience.org/library/papers/40002825 | PubMed |
| 39803022 | Exploring New and Potential Indications for Botulinum Toxin Treatment: An Updated Literature Review. | Cureus | 2024 | https://conductscience.org/library/papers/39803022 | PubMed |
| 38601787 | Diplopia Secondary to Neurotoxin Injections: Prevention, Diagnosis, and Management. | J Clin Aesthet Dermatol | 2024 | https://conductscience.org/library/papers/38601787 | PubMed |
| 38393175 | From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/38393175 | PubMed |
| 37499079 | The pluripotential evolution and journey of Botox (onabotulinumtoxinA). | Medicine (Baltimore) | 2023 | https://conductscience.org/library/papers/37499079 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37499080
GET https://conductscience.org/api/papers/v1/37499080/references?page=2